10x Genomics, Inc. TXG Spatial — Total Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s spatial — total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s spatial — total revenue?
- 10x Genomics, Inc. (TXG) reported spatial — total revenue of $40.91M in Q1 2026.
- How has 10x Genomics, Inc.'s spatial — total revenue changed year-over-year?
- 10x Genomics, Inc.'s spatial — total revenue increased by 30.9% year-over-year, from $31.25M to $40.91M.
- What is the long-term trend for 10x Genomics, Inc.'s spatial — total revenue?
- Over 4 years (2021 to 2025), 10x Genomics, Inc.'s spatial — total revenue has grown at a 50.8% compound annual growth rate (CAGR), from $27.86M to $143.98M.
- What does spatial — total revenue mean?
- This metric captures the aggregate revenue derived from all products and services within the spatial biology segment, including both hardware and recurring consumable kits. It measures the overall commercial success and market penetration of the company's spatial analysis portfolio. Tracking this total provides insight into the segment's contribution to the company's top-line performance and its ability to monetize the full lifecycle of its research solutions.